Medicare spending $9B on hepatitis C drugs
WASHINGTON - New government figures show Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion.
That's going to raise insurance costs for all beneficiaries, whether or not they have the liver-wasting disease.
Cost estimates show that Medicare's popular prescription drug program will spend more than $9 billion on hepatitis C drugs this year, a 96 percent increase from $4.7 billion in 2014.
"Hep C" is a viral illness affecting some 3 million people in the U.S. and claims more lives here than AIDS. More than 3 in 4 adults currently infected are baby boomers, the age group now entering Medicare.
New drugs cure the disease, but treatment costs from $80,000 to $100,000. Drug prices are the public's top health care concern in opinion polls.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
High School graduates grateful for different, yet meaningful commencement ceremony
Louisiana closing in on 200k test goal for May; tracking 'reasonably well'...
Hurricane season and the pandemic - Shelters during COVID-19
Crash on I-10 at Siegen Lane leaves 3 injured
I-10 widening project at EBR-Ascension line nears completion
Southern baseball players meet for unofficial practice in Port Allen
Kenan Cooper is first from West Feliciana to swim collegialety
LSU rolls out new turf in Tiger Stadium overnight
LSU Coaches dish on latest with football team
New West Feliciana football coach unsure of when he'll meet his new...